MTOR and cancer: Moreover, dioscin has shown its antitumor activity in various types of cancer, including lung 20, colorectal 12, prostate 21, gastric 22, ovarian 23, and laryngeal 24 cancers through JNK, MAPK, and Akt/mTOR signaling 20, 23.